Grappling With Galaxies: Basic Questions Persist

After years of passivity, the astronomy community is protesting telescope closings, cramped quarters, and scanty maintenance Our understanding of galaxies is at a primitive level, and we are still perplexed by basic questions. For instance: 1. Why do things such as galaxies exist at all, with their observed characteristic dimensions—typically 10^11 stars within radii of about 10^4 parsecs? 2. What is the dark matter that constitutes so large a part of galaxies?We know that more than 9O

Written byMartin Rees
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Our understanding of galaxies is at a primitive level, and we are still perplexed by basic questions. For instance:

1. Why do things such as galaxies exist at all, with their observed characteristic dimensions—typically 10^11 stars within radii of about 10^4 parsecs?

2. What is the dark matter that constitutes so large a part of galaxies?We know that more than 9O% of their mass is unaccounted for and that the visible content of galaxies is embedded in a diffuse “halo” of dark matter that may be 10 times as massive.

3. Why do the central nuclei of some galaxies flare up (especially at redshifts z=2) outshining the entire host galaxies, and what remnants of this activity are left behind?

Possible answers are now coming into focus as astrophysicists and cosmologists increasingly concentrate on these questions, which are some of the most important ones in physics today.

Galaxies must have evolved ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies